Surgiphor Solution for Preventing Infections After Joint Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a special solution called Surgiphor to determine its effectiveness in preventing infections after hip or knee replacement surgeries. Researchers compare Surgiphor to regular saline (salt water) to assess whether it better reduces infection risk during the first 90 days post-surgery. It targets individuals needing hip or knee revision surgery for non-infection reasons. Participants must not have allergies to iodine, a key ingredient in Surgiphor. As an unphased trial, this study allows participants to contribute to important research that could enhance surgical outcomes for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team for guidance.
What prior data suggests that Surgiphor Irrigation Solution is safe for preventing infections after joint surgery?
Research shows that povidone-iodine (PVP-I) solutions, such as Surgiphor, can significantly reduce the risk of infections after surgery. Studies have found that this type of solution effectively cleans wounds during surgery by removing germs and dirt.
Regarding safety, no major risks have been reported with povidone-iodine irrigation. The only noted effect is an increase in iodine levels in the blood post-surgery, which is not considered harmful. The Surgiphor system is designed to be sterile, minimizing any risk of contamination during use.
Overall, research suggests that Surgiphor is safe and well-tolerated for surgeries, such as joint replacements, making it a promising option for preventing infections after these procedures.12345Why are researchers excited about this trial?
Surgiphor is unique because it uses a sterile povidone iodine irrigation solution, which combines 0.5% PVP-I with 0.9% saline, potassium iodide, and a phosphate buffer. Unlike the standard antiseptics used in joint surgeries, such as chlorhexidine or plain saline, Surgiphor includes Vitamin E TPGS, which is known for its antioxidant properties and may aid in wound healing. Researchers are excited about Surgiphor because it potentially offers enhanced infection prevention with its multifaceted formulation, addressing both microbial threats and supporting tissue recovery.
What evidence suggests that Surgiphor Irrigation Solution is effective for preventing infections after joint surgery?
Research has shown that antiseptic solutions like Surgiphor, which participants in this trial may receive, can help reduce infections after surgery. One study found that these solutions prevent infections more effectively than those without antibacterial properties. Surgiphor, a sterile liquid, cleans the surgical area and lowers the risk of infection. Although some studies on povidone-iodine (an important ingredient) suggest it may not always provide extra benefits in certain surgeries, Surgiphor's unique formula might offer better protection. The main goal is to keep the surgical site clean and free from bacteria to reduce infections. Participants in this trial may also receive sterile saline as a comparator to evaluate Surgiphor's effectiveness.16789
Are You a Good Fit for This Trial?
This trial is for adults over 18 who need a total hip or knee revision surgery and can give informed consent. It's not for those with iodine allergies, life expectancy less than one year, or women who are pregnant or breastfeeding.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Surgiphor or sterile saline irrigation solution during revision arthroplasty
Follow-up
Participants are monitored for acute prosthetic joint infection and other complications
What Are the Treatments Tested in This Trial?
Interventions
- Sterile Saline
- Surgiphor Irrigation Solution
Find a Clinic Near You
Who Is Running the Clinical Trial?
Center for Innovation and Research Organization
Lead Sponsor